AVANOS MEDICAL INC (AVNS) Stock Price & Overview

NYSE:AVNS • US05350V1061

Current stock price

13.95 USD
-0.14 (-0.99%)
At close:
13.95 USD
0 (0%)
After Hours:

The current stock price of AVNS is 13.95 USD. Today AVNS is down by -0.99%. In the past month the price increased by 1.16%. In the past year, price increased by 3.95%.

AVNS Key Statistics

52-Week Range9.303 - 15.68
Current AVNS stock price positioned within its 52-week range.
1-Month Range12.75 - 14.27
Current AVNS stock price positioned within its 1-month range.
Market Cap
648.815M
P/E
14.84
Fwd P/E
13.66
EPS (TTM)
0.94
Dividend Yield
N/A

AVNS Stock Performance

Today
-0.99%
1 Week
+0.72%
1 Month
+1.16%
3 Months
+24.78%
Longer-term
6 Months +18.32%
1 Year +3.95%
2 Years -22.84%
3 Years -52.78%
5 Years -67.72%
10 Years N/A

AVNS Stock Chart

AVANOS MEDICAL INC / AVNS Daily stock chart

AVNS Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS turns out to be only a medium performer in the overall market: it outperformed 66.46% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AVNS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AVNS. Both the profitability and the financial health of AVNS get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVNS Earnings

On February 24, 2026 AVNS reported an EPS of 0.29 and a revenue of 180.90M. The company beat EPS expectations (14.64% surprise) and beat revenue expectations (1.52% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported$0.29
Revenue Reported180.9M
EPS Surprise 14.64%
Revenue Surprise 1.52%

AVNS Forecast & Estimates

For the next year, analysts expect an EPS growth of 8.62% and a revenue growth 2.16% for AVNS


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y8.62%
Revenue Next Year2.16%

AVNS Groups

Sector & Classification

AVNS Financial Highlights

Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -25.4% compared to the year before.


Income Statements
Revenue(TTM)701.20M
Net Income(TTM)-72.90M
Industry RankSector Rank
PM (TTM) N/A
ROA -6.79%
ROE -9.37%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%-30.95%
Sales Q2Q%0.72%
EPS 1Y (TTM)-25.4%
Revenue 1Y (TTM)1.95%

AVNS Ownership

Ownership
Inst Owners97.21%
Shares46.51M
Float44.39M
Ins Owners2.94%
Short Float %5.26%
Short Ratio3.85

About AVNS

Company Profile

AVNS logo image Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

Company Info

IPO: 2014-10-21

AVANOS MEDICAL INC

5405 Windward Parkway, Suite 100 South

Alpharetta GEORGIA 30004 US

CEO: Joseph F. Woody

Employees: 2227

AVNS Company Website

AVNS Investor Relations

Phone: 18444282667

AVANOS MEDICAL INC / AVNS FAQ

Can you describe the business of AVANOS MEDICAL INC?

Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.


What is the current price of AVNS stock?

The current stock price of AVNS is 13.95 USD. The price decreased by -0.99% in the last trading session.


Does AVANOS MEDICAL INC pay dividends?

AVNS does not pay a dividend.


What is the ChartMill technical and fundamental rating of AVNS stock?

AVNS has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Is AVANOS MEDICAL INC (AVNS) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVNS.


What is the Short Interest ratio of AVANOS MEDICAL INC (AVNS) stock?

The outstanding short interest for AVANOS MEDICAL INC (AVNS) is 5.26% of its float.